XML 378 R74.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVE WARRANT LIABILITY (Details Narrative)
12 Months Ended
Dec. 03, 2024
USD ($)
$ / shares
shares
Dec. 03, 2024
CAD ($)
$ / shares
Sep. 25, 2024
USD ($)
$ / shares
shares
Sep. 25, 2024
CAD ($)
$ / shares
Jul. 19, 2024
USD ($)
$ / shares
shares
Jul. 19, 2024
CAD ($)
Dec. 04, 2023
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Sep. 23, 2024
$ / shares
IfrsStatementLineItems [Line Items]                      
Proceeds from issuing shares $ 25,000,002 $ 35,000,003 $ 15,000,000 $ 20,400,000 $ 10,000,000 $ 13,700,003 $ 1,607,400        
Number of shares issued | shares 5,555,556   4,000,000   3,333,334   1,786,000        
Exercise price | $ / shares $ 6.00       $ 4.00   $ 1.12       $ 5.09
Expected dividend as percentage, share options granted 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%  
Risk free interest rate, share options granted 2.91% 2.91% 2.79% 2.79% 3.35% 3.35% 3.54% 2.93% 3.54%    
Expected volatility, share options granted 88.05% 88.05% 87.63% 87.63% 85.93% 85.93% 75.66% 88.05% 75.66% 83.51%  
Description of expected estimated life 5 years 5 years 5 years 5 years 5 years 5 years 5 years        
Derivative financial liabilities | $             $ 954,537        
Description of expected common shares 5 years 5 years 5 years 5 years 5 years 5 years          
Warrant | $ $ 8,127,620   $ 4,842,347   $ 6,430,362            
Share price | (per share) $ 4.50 $ 6.29 $ 3.75 $ 5.10       $ 2.12 $ 4.11 $ 3.32  
Warrants exercised | shares               1,598,200      
Increase (decrease) in reimbursement rights related to defined benefit obligation, resulting from gain (loss) on remeasurement | $               $ 20,631,082 $ 24,865  
Warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares 2,777,778   2,000,000   3,333,334   1,786,000